Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

John Marsden

Showing results (141-150 of 145) with videos related to

Pageof 15
Sort By:
You have reached the last page of results.This site can display upto 145 results.
Eclinicalmedicine|December 4, 2023
Superiority and cost-effectiveness of monthly extended-release buprenorphine versus daily standard of care medication: a pragmatic, parallel-group, open-label, multicentre, randomised, controlled, phase 3 trialJohn Marsden, Mike Kelleher, Eilish Gilvarry, et al.
Trials|August 19, 2022
Extended-release pharmacotherapy for opioid use disorder (EXPO): protocol for an open-label randomised controlled trial of the effectiveness and cost-effectiveness of injectable buprenorphine versus sublingual tablet buprenorphine and oral liquid methadoneJohn Marsden, Mike Kelleher, Zoë Hoare, et al.
Trials|January 29, 2021
Core outcomes set for research on the treatment of opioid use disorder (COS-OUD): the National Institute on Drug Abuse Clinical Trials Network protocol for an e-Delphi consensus studyNiranjan S Karnik, Cynthia I Campbell, Megan E Curtis, et al.
Health Technology Assessment (Winchester, England)|November 4, 2023
Adjunctive Medication Management and Contingency Management to enhance adherence to acamprosate for alcohol dependence: the ADAM trial RCTKim Donoghue, Sadie Boniface, Eileen Brobbin, et al.
Addiction (Abingdon, England)|March 16, 2022
The opioid use disorder core outcomes set (OUD-COS) for treatment research: findings from a Delphi consensus studyNiranjan S Karnik, John Marsden, Connor McCluskey, et al.
Pageof 15

Showing results (141-150 of 145) with videos related to

Sort By:
Pageof 15
You have reached the last page of results.This site can display upto 145 results.
Eclinicalmedicine|December 4, 2023
Superiority and cost-effectiveness of monthly extended-release buprenorphine versus daily standard of care medication: a pragmatic, parallel-group, open-label, multicentre, randomised, controlled, phase 3 trialJohn Marsden, Mike Kelleher, Eilish Gilvarry, et al.
Trials|August 19, 2022
Extended-release pharmacotherapy for opioid use disorder (EXPO): protocol for an open-label randomised controlled trial of the effectiveness and cost-effectiveness of injectable buprenorphine versus sublingual tablet buprenorphine and oral liquid methadoneJohn Marsden, Mike Kelleher, Zoë Hoare, et al.
Trials|January 29, 2021
Core outcomes set for research on the treatment of opioid use disorder (COS-OUD): the National Institute on Drug Abuse Clinical Trials Network protocol for an e-Delphi consensus studyNiranjan S Karnik, Cynthia I Campbell, Megan E Curtis, et al.
Health Technology Assessment (Winchester, England)|November 4, 2023
Adjunctive Medication Management and Contingency Management to enhance adherence to acamprosate for alcohol dependence: the ADAM trial RCTKim Donoghue, Sadie Boniface, Eileen Brobbin, et al.
Addiction (Abingdon, England)|March 16, 2022
The opioid use disorder core outcomes set (OUD-COS) for treatment research: findings from a Delphi consensus studyNiranjan S Karnik, John Marsden, Connor McCluskey, et al.
Pageof 15